The 24th International Symposium on Electro- and Liquid Phase- Separation Techniques (ITP 2017)
The 24th International Symposium on Electro- and Liquid Phase- Separation Techniques (ITP 2017) will be held in Sopot, Poland, at the Sheraton Hotel, 10–13 September 2017.
One of the most recognized international symposium series, the 24th International Symposium on Electro- and Liquid Phase- Separation Techniques (ITP 2017)addresses the latest discoveries, developments, and production in all areas of electro- and liquid phaseâseparation techniques in multiple disciplines.
The organizers are pleased to announce that ITP 2017 will be held in Sopot, Poland, at the Sheraton Hotel, 10–13 September 2017.
The 24th ITP will continue the tradition of the series by updating attendees on the advances in different separation techniques and their applications in various areas with an emphasis on pharmaceutical and environmental analysis.
The dynamic 2017 programme will again highlight a wide range of technologies that use electro- and liquid phase- separations, such as capillary and microchip electrophoresis, electrokinetic chromatography and electrochromatography, two-dimensional electrophoresis, high performance liquid chromatography (HPLC), ultrahigh-pressure liquid chromatography (UHPLC), micro- and nano-scale HPLC.
One of the major aims of the symposium is to provide a forum for highâlevel scientific exchange between analytically oriented scientists from the whole world in a friendly atmosphere. Sopot, with its special atmosphere, can offer excellent opportunities for scientific, cultural, and social experiences in a unique seaside setting.
ITP 2017 will also be running three stimulating and highly informative workshops by recognized experts in their field, which will be run in parallel on Sunday 10 September from 9:00 to 13:00. These workshops include:
Workshop 1: Fundamentals of Sample Preparation and Recent Developments in Microextraction Technologies – Where “Big” Fails “Small” Can Do More - Barbara Bojko, Nicolaus Copernicus University, Poland, and Janusz Pawliszyn, University of Waterloo, Canada
Workshop 2: Challenges in Analytical Development: The Need in Orthogonal Chromatographic Methods for a Small Molecule Project in Innovative Drug Development - Vladimir Ioffe, Teva Pharmaceutical Industries, Ltd., Israel
Workshop 3: Principles and Applications of Modern CE-MS - G.W. Somsen, Vrije Universiteit Amsterdam, The Netherlands
Furthermore, participants are invited to submit manuscripts based on presentations at the IPT 2017 meeting for possible publication in the Journal of Chromatography A, with the intention of publishing a Virtual Special Issue (VSI) dedicated to the meeting. This will eliminate possible delays in publication for contributors to the special issue, making the conference special issue more complete and accessible than it has ever been.
Additionally, this year ITP 2017 will be held in parallel with the 11th Polish Conference on Chromatography, the national meeting organized every 3 years.
Oral and poster presentations will be organized during the conference and the organizers encourage interested presenters to submit their abstracts as soon as possible.
More details on the topics, invited speakers, registration, abstract submission, conference fees, and important dates can be found on the conference website: www.itp2017.com or e-mail us at: symposium@itp2017.com
We look forward to seeing you in Sopot!
Prof. MichaÅ Markuszewski
Chairman
AOAC International Awarded NIST Grant for Developing Drug Testing Standards
October 31st 2024The grant will be part of a new collaborative scientific initiative to address the need for standards that define the desired performance of lateral flow immunoassay test strips to detect illicit drugs in tablets and powders.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
